2018 Speakers

 

Advanced combo preliminary speakers confirmed 2018

KEYNOTE SPEAKERS:

Damien Bates, Chief Medical Officer, SanBio, Inc.

Berthold Boedeker, Chief Scientist, Bayer AG

Harald Bradl, Director Cell Culture Development, Boehringer Ingelheim Pharma GmbH & Co. KG

Eduardo Bravo, Chief Executive Officer, TiGenix

Dr Colleen Delaney, Chief Medical Officer, Nohla Therapeutics

Dr Joanne Kurtzberg, Director, Carolinas Cord Blood Bank At Duke

Dr Margo R. Roberts, Chief Scientific Officer, Kite Pharma Inc

Benjamin Shepherd, Associate Director of R&D, Therapeutics, Organovo

Susan L. Solomon, Chief Executive Officer and Co-Founder, New York Stem Cell Foundation

Dr Michael D West, CEO, BioTime, Inc.

 

Advanced Therapies & Regenerative Medicine:

Ajan Reginald , Chief Executive Officer, Celixir
Alain Vertès , Managing Director, NxR Biotechnologies
Alex Pemberton , Programme Manager UKRMP, Medical Research Counci l
André Choulika , Chairman & Chief Executive Officer, Cellectis
Andrea Piccin , Consultant Haematologist, Haematology Dept & BMT Unit, San Maurizio Regional Hospital Bolzano
Benjamin Shepherd , Director, Therapeutics, Organovo
Chaim Lebovits , CEO, Brainstorm Cell Therapeutics
Christoph Neyer , ‎Director Business Development, InGeneron GmbH
Claudia Mitchell , CEO, Universal Cells, Inc.
Damien Bates , Chief Medical Officer & Head of Research, SanBio
David Pettitt , Research Associate, Centre for the Advancement of Sustainable Medical Innovation (CASMI), DPhil Candidate, Medical Sciences, University of Oxford
Didier Caizergues , Head of Regulatory Affairs Department, Genethon
Diego Ardigò , Project Lead, Chiesi Group
Eduardo Bravo , Managing Director and CEO, TiGenix
Gerry Graham , Head, Chemokine Research Group & Deputy Head of the Institute of Infection, Immunity and Inflammation, University of Glasgow
Giulia Detela , Process Design Manager, VivaBioCell S.p.A .
Ian Campbell , Director for Health and Life Sciences, Innovate UK
Ian Hudson , CEO, MHRA
James Miskin , Chief Technical Officer, Oxford BioMedica
James Noble , CEO, Adaptimmune
Jane Lebkowski , ‎President of R&D, Asterias Biotherapeutics
Jeff Abbey , CEO, Argos Therapeutics
Jeffrey Schaffer , Director of Veterinary Professional Services, VetStem
John Campbell , Associate Director, Research, Development & Innovation, SNBTS, National Science Laboratory
John Tchelingerian , CEO, Promethera, Biosciences
Katy Spink , Chief Operating Officer, Asterias Biotherapeutics
Kristin Comella , Chief Science Officer, US Stem Cell Inc.
Marc Turner , Medical Director, SNBTS
Marcie Glicksman , CSO, Orig3n
Margo Roberts , CSO, Kite Pharma
Mark Zimmerman , Vice President, Business Development and Strategy, ViaCyte
Mehis Pilv , Cofounder and Managing Director, GeneCode Ltd
Michael West , CEO, BioTime
Michele Lipucci , CAT Full Member, Patients’ representative, EMA
Nick Crabb , Programme Director – Scientific Affairs, NICE
Norio Nakatsuji , Founding Director, Institute for Integrated Cell-Material Sciences (iCeMS) , Kyoto University, Kyoto, Japan
Ohad Karnieli , Chair, Process and Product Development Subcommittee, ISCT ; CEO & Co-Founder, ATVIO
Pascale V Guillot , Head of the Cellular Reprogramming & Perinatal Therapy Team, Institute for Women’s Health UCL
Paul Peter Tak , Professor of Medicine, Rheumatology, Academic Medical Center, University of Amsterdam AMC (Senior Vice President of Research and Development Pipeline and Chief Immunology Officer, GSK & Board Member, Galvani)
Peder Olofsson , Leader, Center for Bioelectronic Medicine, Department of Medicine, Karolinska Institutet
Qasim Rafiq , Senior Lecturer in Bioprocessing of Regenerative, Cellular and Gene Therapy, UCL
Roger Smith , Professor, Equine Orthopaedics, Royal Veterinary College (RVC)
Stephen Badylak , Professor, Department of Surgery, Deputy Director of the McGowan Institute for Regenerative Medicine (MIRM), & Director, Center for Pre-Clinical Tissue Engineering within the Institute
Susan Solomon , CEO and Co-Founder, New York Stem Cell Foundation
Suzanne S. Farid , Professor of Bioprocess Systems Engineering, UCL
Todd McAllister , Executive Director, Amnion Foundation
Václav Procházka , Deputy Director for Science & Research, University Hospital Ostrava
Yen Choo , CEO, Progenitor Therapeutics
Zami Aberman , Chairman & CEO, Pluristem Therapeutics
R epresentative from Cellgenix
Representative from ThermoFisher
Representative from Cryoport
Representative from Terumo
 
 

Cell Culture:

Ajoy Velayudhan
Alessandro Butte , Senior Researcher, ETH Group
Berthold Boedeker , Chief Scientist, Global Drug Discovery – Global Biologics Biotech Development, Bayer AG
Charles Haynes , Chemical & Biological Engineering, University of British Columbia
Christoph Herwig , Professor of Biochemical Engineering, Vienna University of Technology ; Founder & Scientific Advisor, Exputec
Cornelia Kasper , Full University Professor, BOKU
Cristiana Boi , President,  European Membrane Society , Assistant Professor, DICAM
David Brindley , Chief Scientific Officer, Aegate ; Managing Partner, IP Asset Ventures ; Senior Research Fellow, University of Oxford
Dylan Jones , Principal Scientist, Genzyme
Hansjörg Hauser , Dept. of Scientific Strategy, Helmholtz Centre for Infection Research GmbH
Harald Bradl , Director & Head of Cell Culture Development, Boehringer Ingelheim
Helene Faustraup-Kildegaard , Senior Researcher and Co PI, Technical University of Denmark
Hitto Kaufmann , Global Vice President of Biopharmaceutical Development and Platform Innovation, Sanofi
Joachim Häfner , Senior Transfer Engineer, Boehringer Ingelheim
Kumar Dhanasekharan , Senior Director & Head, Biologics Process & Analytical Development, Amicus Therapeutics
Manuel J T Carrondo , Professor of Chemical & Biochemical Engineering, FCT-UNL, Vice-President, IBET
Marijke Wynants , MSAT Lead, Sanofi
Massimo Morbidelli , Professor of Chemical and Bio Engineering, ETH Zurich
Nicolas Urbieta , USP Process Scientist, BST / BioRealization, Sanofi
Oliver Spadiut , Integrated Bioprocess Development, Chemical Engineering, TU Wien
Otto Wilhelm-Merten , Head of Applied Vectorology and Innovation group, Genethon
Paula Meleady , Associate Director, National Institute for Cellular Biotechnology
Representative from Sartorius
Sergey A. Piletsky , Professor of Bioanalytical Chemistry, Chemistry Department, College of Science & Engineering, University of Leicester
Sergey Piletsky , Professor in Bioanalytical Chemistry, University of Leicester
Tudor Arvinte , CEO, Therapeomic Inc. Basel , Professor, University of Geneva
Veronique Chotteau , Principal Investigator, Cell Technology Group, School of Biotechnology, KTH – Royal Institute of Technology
 
 

Cord Blood:

Alexander Platz , MD, DKMS Cord Blood Bank 
André Gerth , Chief Executive Officer, Vita 34
Andre Gomes , CEO, Stemlab
Andrea Piccin , Consultant Haematologist, San Maurizio Regional Hospital
Beth Shaz , Chief Medical Officer, New York Blood Centre
Cherie Daly , Medical Affairs, LifeBankUSA
Chiranya (Anjie) Prachaseri , CEO, South East Asia, Cryoviva
Christine Hauskeller , Associate Professor, University of Exeter
Colleen Delaney , Founder and Chief Medical Officer, Nohla Therapeutics, Full Member and Director of the Program in Cord Blood Transplantation, Fred Hutchinson Cancer Research Centre
Daniel Surbek , Professor, Acting Chairman, Department of Gynaecology and Obstetrics, University Hospital Bern
Glyn Stacey , Director, UK Stem Cell Bank
Gocha Shatirishvili , Medical Director, Geocord
Guy Sauvageau , CEO, Scientific Founder and CSO, ExCellThera
Hector Mayani , Head, Oncology Research Unit, IMSS National Medical Center, Cordon Vital
Helen Papadaki , Professor of Haematology, University of Crete, Head of the Department of Haematology, Public Cord Blood Bank of Crete
Irene Martini , Owner & Scientific Director, SmartBank ; CEO Nanog International ; Advisory Board Member, Parent’s Guide to Cord Blood Foundation
Jaap Boeleans , Haematology Consultant, Blood and Marrow Transplantation program, UMC Utrecht
Jane Apperley , Chair of the Department of Haematology, Imperial College London
Joana Correia , Executive Director and CSO, Exogenus Therapeutics
Joanne Kurtzberg , Director, Carolinas Cord Blood Bank , Chief Scientific Officer, Robertson Clinical & Translational Cell Therapy Program , Director, Pediatric Blood and Marrow Transplant Program
 

Artificial Intelligence in Healthcare:

Patrick Keohane , CMO, Benevolent AI
Jun Dong , Director, Business Partner for Global Regulatory Affairs and Development, Information Technology Solution, Sanofi
Brandon Allgood , CEO, Numerate
Melind Kamkolar , CDO, Sanofi
Rangaprasad Sarangarajan , CSO & SVP, Berg
 
 

Precision Medicine

Julien De Salaberry , Founder, The Asia HealthTech Connector
David Smith , Professor, Mayo Clinic
Jay Goth , Forentis Fund Manager, F orentis Fund
Marie-Claire Parker , Business Development Manager, Scottish Stratified Innovation Medical Center
Marilyn Robertson , Health Science Scotland Manager, Scottish Stratified Innovation Medical Center
Tony Freemont , Professor of Osteoarticular Pathology, Manchester University
Melina Kalofonou , Postdoctoral Researcher, Imperial College London
Julia Wilson , Wellcome, Associate Director, Trust Sanger Institute

Janette Rawlinson , Lay Member, CRUK Stratified Medicine

 

DOWNLOAD PROSPECTUS

 

To exhibit or sponsor call Erica Baeta on
+44(0) 207 092 1152 or email erica.baeta@terrapinn.com

 

 

 

The World Advanced Therapies & Regenerative Medicine Congress is two events: a world-class conference where hundreds of pharma, biotech and academia leaders from around the planet meet; and, a fantastic exhibition to which we’re expecting around 1,000 visitors. To visit the show is free. There is, naturally, a registration fee to attend the conference.

CONTACT US
phone: +44 (0)207 092 1237
email:
 
jessica.robinson@terrapinn.com